Skip to content
Home/Companies/Pharma/GTP Bioways

GTP Bioways

Pharma·France·Exited 2024·Held 5yr
Entry
2019
Hold
5yr
Exit
2024

Who owns GTP Bioways?

GTP Bioways is a French Pharma company, now owned by Olon Group, which acquired it in 2024 from Merieux Equity Partners.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
Merieux Equity Partners
Investor
Merieux Equity Partners
Mérieux Participations 3 · 2019 · Buyout

Key facts

HQFrance
SectorPharma
Exit Type
Trade Sale
Buyer
Olon Group
Exit Year
2024

More from Mérieux Participations 3

Other portfolio companies in the same fund.

Ceva Sante Animale
Ceva Sante Animale
Exited 2025
PharmaFrance
to ARCHIMED
Janvier Labs
Janvier Labs
Active
HealthcareFrance· 2022
Dental Monitoring
Dental Monitoring
Active
HealthTechFrance· 2021
Domus VI
Domus VI
Active
HealthcareFrance· 2021
DomusVi
DomusVi
Active
HealthcareFrance· 2021
SERB Pharmaceuticals
SERB Pharmaceuticals
Active
PharmaBelgium· 2021

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Advantice Health
Advantice Health
Active
TA AssociatesUS
Alcala Farma
Active
Advent InternationalSpain
Alvogen
Alvogen
Active
CVC Capital Partners
Anovo
Anovo
Active
ArdianUS

Questions

Who owns GTP Bioways?

GTP Bioways is now owned by Olon Group, which acquired it in 2024 from Merieux Equity Partners.

When did Olon Group acquire GTP Bioways?

Olon Group acquired GTP Bioways in 2024, buying from Merieux Equity Partners.

Who did GTP Bioways sell to?

Merieux Equity Partners sold GTP Bioways to Olon Group in 2024 (Trade Sale).

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue